‘유전자 가위’ 기술 이용세계 최초 치료제 영국에 이어 미국에서도 승인: 크리스퍼 CRISPR FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease

CRISPR 2.0: a new wave of gene editors heads for clinical trials FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease https://www.nature.com/articles/d41586-023-03797-7 [개관] Genome Editing * 크리스퍼 CRISPR = 3세대 유전자 가위(RGENs, RNA-guided engineered nucleases) 크리스퍼 (CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats) 시스템은 세균 등에서 발견되는 적응 면역 기작으로, 현재는 이를 응용한 유전체 편집..

원문링크 : ‘유전자 가위’ 기술 이용세계 최초 치료제 영국에 이어 미국에서도 승인: 크리스퍼 CRISPR FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease